Photo of Marcus Darrabie, MD

Marcus Darrabie, MD

General Surgeon

Expertise of Marcus Darrabie, MD

6 items. To interact with these items, press Control-Option-Shift-Right Arrow
Item 1 of 6
Biography

Marcus D. Darrabie, MD, is board certified in general surgery and surgical critical care. He specializes in the management of critically ill and postoperative patients, including trauma victims. Dr. Darrabie provides expert critical care medicine diagnoses and treats and supports patients with multiple organ dysfunction. Additionally, he also performs elective, minimally invasive laparoscopic, and open procedures. His outstanding credentials include his medical degree from Duke University. Dr. Darrabie completed his surgical residency and advanced fellowship training in critical care at Duke, where he was twice awarded the Duke University School of Medicine Appleseed Resident Teaching Award. He went on to complete an additional surgical critical care fellowship at the University of Florida. Dr. Darrabie serves as an instructor of surgery at the University of Central Florida College of Medicine and Florida State College of Medicine. He is an active researcher and widely published in the field of critical care medicine.

Item 2 of 6
Education

Duke University Hospital; College of Medicine at the University of Florida; Duke University Medical Center

Item 3 of 6
Residency

Duke University Medical Center; Duke University School of Medicine

Item 4 of 6
Fellowship

College of Medicine at the University of Florida, Gainesville, FL

Item 5 of 6
Specialty

Center for Specialized Surgery

Item 6 of 6
Board Certifications

American Board of Surgery

Publications of Marcus Darrabie, MD
  • Toll-like receptor activation as a biomarker in traumatically injured patients
    , JOURNAL OF SURGICAL RESEARCH

  • Resuscitative Endovascular Balloon Occlusion of the Aorta: Implementation and Preliminary Results at an Academic Level I Trauma Center
    , JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

  • Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation
    , PHYSIOLOGICAL REPORTS

    More sources loaded

  • Creatine Supplementation Reduces Doxorubicin-Induced Cardiomyocellular Injury
    , CARDIOVASCULAR TOXICOLOGY

  • Increased yield of endothelial cells from peripheral blood for cell therapies and tissue engineering
    , REGENERATIVE MEDICINE

  • Removal of Potential Phosphorylation Sites does not Alter Creatine Transporter Response to PKC or Substrate Availability
    , CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

  • Hepatic Resection for Hepatocellular Carcinoma: Do Contemporary Morbidity and Mortality Rates Demand a Transition to Ablation as First-Line Treatment?
    , JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

  • Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer
    , JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

  • Exposing cardiomyocytes to subclinical concentrations of doxorubicin rapidly reduces their creatine transport
    , AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

  • AMPK and substrate availability regulate creatine transport in cultured cardiomyocytes
    , AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM